Results 141 to 150 of about 1,671 (156)

Pantothenate kinase-associated neurodegeneration

2023
openaire   +1 more source

Pantothenate kinase-associated neurodegeneration

2008
Frank Gaillard, Rohit Sharma, Ahmed BenSalem   +2 more
openaire   +1 more source

The FOsmetpantotenate Replacement Therapy (FORT) randomized, double-blind, Placebo-controlled pivotal trial: Study design and development methodology of a novel primary efficacy outcome in patients with pantothenate kinase-associated neurodegeneration

Clinical Trials, 2019
Thomas Klopstock, Maria L Escolar, Aleksandar Videnovic   +2 more
exaly  

PANK2p.A170fs：a novel pathogenetic mutation, compound withPANK2p.R440P, causing pantothenate kinase Associated neurodegeneration in a Chinese family

International Journal of Neuroscience, 2020
Wen-Juan Wang, Ze Yang, Fanyi Zeng
exaly  

Pantothenate Kinase-Associated Neurodegeneration

2015
openaire   +1 more source

Pantothenate kinase 2 mutation with classic pantothenate-kinase-associated neurodegeneration without ‘eye-of-the-tiger’ sign on MRI in a pair of siblings

Pediatric Radiology, 2006
Hishām Dahmoush, Dawn E Saunders, Robert Surtees   +2 more
exaly  

Novel compound heterozygous mutations in thePANK2 gene in a Chinese patient with atypical pantothenate kinase-associated neurodegeneration

Movement Disorders, 2005
Yu-Hu Zhang, Beisha Tang, Kun Xia
exaly  

Decreasing iron neurotoxicity in pantothenate kinase-associated neurodegeneration

The Lancet Neurology, 2019
Scott, Ayton, Ashley I, Bush
openaire   +2 more sources

Subthalamic Nuclei Stimulation in Patients With Pantothenate Kinase-Associated Neurodegeneration (PKAN)

Neuromodulation, 2017
Ziyuan Liu, Yingmai Yang, Wanchen Dou
exaly  

Grey matter alterations in patients with Pantothenate Kinase-Associated Neurodegeneration (PKAN)

Parkinsonism and Related Disorders, 2014
Herwin Speckter, Eddy Perez-Then, Jairo Oviedo   +2 more
exaly